Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-273.99%
operating margin TTM
-267.29%
revenue TTM
1.87 Million
revenue per share TTM
0.16$
valuation ratios | |
|---|---|
| pe ratio | -0.00 |
| peg ratio | -0.00 |
| price to book ratio | -0.00 |
| price to sales ratio | 0.00 |
| enterprise value multiple | 0.42 |
| price fair value | -0.00 |
profitability ratios | |
|---|---|
| gross profit margin | 54.83% |
| operating profit margin | -267.29% |
| pretax profit margin | -273.99% |
| net profit margin | -273.99% |
| return on assets | -147.11% |
| return on equity | -768.84% |
| return on capital employed | -458.24% |
liquidity ratios | |
|---|---|
| current ratio | 1.20 |
| quick ratio | 0.75 |
| cash ratio | 0.19 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 463.11 |
| operating cycle | 554.72 |
| days of payables outstanding | 249.63 |
| cash conversion cycle | 305.10 |
| receivables turnover | 3.98 |
| payables turnover | 1.46 |
| inventory turnover | 0.79 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.72 |
| debt equity ratio | -1.47 |
| long term debt to capitalization | 4.18 |
| total debt to capitalization | 3.13 |
| interest coverage | -45.03 |
| cash flow to debt ratio | -1.40 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.49 |
| cash per share | 0.06 |
| operating cash flow per share | -0.49 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.40 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -389.62 |
Frequently Asked Questions
When was the last time Bionik Laboratories Corp. (PNK:BNKL) reported earnings?
Bionik Laboratories Corp. (BNKL) published its most recent earnings results on 30-09-2023.
What is Bionik Laboratories Corp.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Bionik Laboratories Corp. (PNK:BNKL)'s trailing twelve months ROE is -768.84%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Bionik Laboratories Corp. (BNKL) currently has a ROA of -147.11%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BNKL's net profit margin stand at?
BNKL reported a profit margin of -273.99% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BNKL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.20 in the most recent quarter. The quick ratio stood at 0.75, with a Debt/Eq ratio of -1.47.